Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden

by Victoria E. Wang, Anatoly Urisman, Lee Albacker, Siraj Ali, Vincent Miller, Rahul Aggarwal, David Jablons
Published 2017-09-01